» Articles » PMID: 20084464

Initial Development of the Temporary Utilities Index: a Multiattribute System for Classifying the Functional Health Impact of Diagnostic Testing

Overview
Journal Qual Life Res
Date 2010 Jan 20
PMID 20084464
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The effects of testing and screening on quality of life may influence the future behavior of society, but have not been quantified. We derived a health classification and survey items for the morbidities of testing and screening, to be the foundation of a multiattribute utility instrument, the Temporary Utilities Index.

Methods: Seventy-six women ranked the importance of attributes of the testing process after breast biopsy. Seven survey items on the testing process were subsequently developed and assessed for clarity by a second group of 19 patients. The items cover attributes of mental and physical well-being before, during, and after testing. A survey panel of 164 subjects accessed online used the items to endorse expected and experienced effects of colon screening and mammography. They also endorsed items from a colorectal benefits and barriers scale, a risk perception scale, and EQ-5D, to utilize in the analyses of validity of the TUI items.

Results: Based on criteria from the literature and limited psychometric analysis, the items showed evidence of practicality, validity, and a strong association with barriers.

Conclusions: The TUI health classification and survey items show evidence of validity, and may inform economic analysis, once combined with utility weights.

Citing Articles

Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Engel L, Bryan S, Whitehurst D Pharmacoeconomics. 2021; 39(12):1383-1395.

PMID: 34423386 DOI: 10.1007/s40273-021-01074-x.


Percutaneous breast biopsy: effect on short-term quality of life.

Humphrey K, Lee J, Donelan K, Kong C, Williams O, Itauma O Radiology. 2014; 270(2):362-8.

PMID: 24471385 PMC: 4228748. DOI: 10.1148/radiol.13130865.


Patient and societal value functions for the testing morbidities index.

Swan J, Kong C, Lee J, Itauma O, Halpern E, Lee P Med Decis Making. 2013; 33(6):819-38.

PMID: 23689044 PMC: 3817009. DOI: 10.1177/0272989X13487605.


Patient-centered outcomes in imaging: quantifying value.

Carlos R, Buist D, Wernli K, Swan J J Am Coll Radiol. 2012; 9(10):725-8.

PMID: 23025867 PMC: 3810945. DOI: 10.1016/j.jacr.2012.06.008.


The economic burden of incidentally detected findings.

Ding A, Eisenberg J, Pandharipande P Radiol Clin North Am. 2011; 49(2):257-65.

PMID: 21333777 PMC: 3094927. DOI: 10.1016/j.rcl.2010.11.004.

References
1.
Hawthorne G, Richardson J, Osborne R . The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res. 1999; 8(3):209-24. DOI: 10.1023/a:1008815005736. View

2.
Parkin D, Devlin N . Is there a case for using visual analogue scale valuations in cost-utility analysis?. Health Econ. 2006; 15(7):653-64. DOI: 10.1002/hec.1086. View

3.
Eckman M, Steere A, Kalish R, Pauker S . Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N Engl J Med. 1997; 337(5):357-63. DOI: 10.1056/NEJM199707313370525. View

4.
Furlong W, Feeny D, Torrance G, Barr R . The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001; 33(5):375-84. DOI: 10.3109/07853890109002092. View

5.
Esfandyari T, Harewood G . Value of a negative colonoscopy in patients with non-specific gastrointestinal symptoms. J Gastroenterol Hepatol. 2007; 22(10):1609-14. DOI: 10.1111/j.1440-1746.2006.04753.x. View